Specialty Pharmacy

Daily doses of sildenafil (Viagra) cut the development of polyps by 50% in mouse models.

Black patients may be eligible for a shorter course of hepatitis C virus treatment.

Biologic drug cannakinumab found to reduce the risk of cardiovascular adverse events among patients with comorbidities.

Individuals who experience high sun exposure during childhood or young adulthood may be less likely to develop multiple sclerosis.

A cellular process could be key to lowering levels of the Huntington disease protein.

Top news of the day from across the health care landscape.

I learned myriad life and professional lessons from my travels.

Tildrakizumab-asmn (Ilumya) approved for the treatment of moderate-to-severe plaque psoriasis.

Matt Gillin, Chief Executive Officer, Relay Network, speaks about how smartphones are crucial to the patient journey.

A PET scan could quickly indicate whether EGRF-targeted therapy would be beneficial to patients with non-small cell lung cancer.

Adding tenofovir disoproxil fumarate to prevention regimens may not effectively stop hepatitis B virus transmission to infants.

Standard colorectal cancer screening guidelines may not accurately assess risks in certain patients.

Top news of the day from across the health care landscape.

The median time to viral suppression decreased from 63 days to 45 days post-rapid entry program.

Brentuximab vedotin (Adcetris) plus chemotherapy may lead to better disease outcomes for patients with classical Hodgkin lymphoma.

American Medical Association survey shows need for reform of the prior authorization process.

ECRM’s innovative event brought together leaders from across specialty pharmacy.

Lisinopril or carvedilol may protect breast cancer patients from experiencing a decline in heart function.

Tobacco may not be to blame for aggressive oral cancers, a new study suggests.

Idebenone was not found to delay disease progression in multiple sclerosis compared with placebo.

Top news of the day from across the health care landscape.

A recently-discovered hepatitis C virus subtype may complicate treatment.

A popular sweetener could result in bacterial overgrowth and symptom worsening among patients with Crohn disease.

Pan-fibroblast growth factor receptor tyrosine kinase inhibitor demonstrates efficacy in urothelial cancer.

Achilles Alon, PharmD, RPh, Director of Specialty Pharmacy, Co-owner of ACE-Rx Specialty Pharmacy, shares complications in treating patients with Crohn's disease.

Several genes observed to protect against neuronal toxicity caused by amyotrophic lateral sclerosis.

Study suggests that supportive care may vary between National Cancer Institute-designated cancer centers and non-designated centers.

Induced neural stem cells may hold the key to reducing multiple sclerosis-related central nervous system damage.